Orthobiologics Market Analysis, Size, Trends | South Korea | 2020-2026 | MedSuite
- Year: 2020
- Scope: 2016-2026
- Region: South Korea
- Pages: 293
- Published Date: 02/11/2020
- Type: MedSuite
By 2020, the South Korean orthobiologics market size was valued at $141.6 million, with over 200,000 bone grafting procedures performed every year. The market size is expected to increase at a compound annual growth rate (CAGR) of 3.6% to reach $181.5 million in 2026.
Throughout this medical market research, we analyzed 16 orthobiologics companies across South Korea and used our comprehensive methodology to understand the market sizes, unit sales, company market shares, and to create accurate forecasts.
While this MedSuite report contains all of the South Korean Orthopedic Biomaterials market data and analysis, each of the market segments is also available as stand-alone MedCore reports. This allows you to get access to only the market research that you need.
DATA TYPES INCLUDED
- Unit Sales, Average Selling Prices, Market Value & Growth Trends
- Forecasts Until 2026, and Historical Data to 2016
- Market Drivers & Limiters for Each Orthopedic Biomaterials Device market
- Competitive Analysis with Market Shares for Each Segment
- Recent Mergers & Acquisitions
- Orthopedic Biomaterials Procedure Volumes
- Disease Overviews and Demographic Information
- Company Profiles, Product Portfolios and SWOT for Top Competitors
- Related Press Releases from Top Competitors
Market Value and Industry Trends
A lack of product differentiation across similar injection cycle products has led to commoditization, which has stifled innovation and the further development of new products. Similar to Japan, the prices of HA viscosupplementation products in South Korea have drastically decreased since their introduction and are among the lowest in the world.
Surgical procedures that require the use of orthopedic biomaterials are generally associated with diseases and indications that become more prevalent in the population with an increase in age, such as osteoarthritis of the spine and knee. By 2020, approximately 15% of South Koreans were aged 65 and over; this proportion is projected to grow steadily over the forecast period, as further cohorts of baby boomers turn 65.
The bone graft substitute market in South Korea is primarily dominated by allografts and DBM allografts. A major driver to their usage is that they are both easily accessible, as they are distributed by several companies and bone banks.
By 2020, the leading competitor in the South Korean orthopedic biomaterials market was Cellumed, which was attributed to its leading position in the orthopedic bone graft substitute market. The company held the second-leading position in the allograft and DBM allograft markets.
JunYoung Medical was the second-leading competitor, which was attributed to its second-leading position in the orthopedic bone graft substitute market. The company held the leading position in the allograft market and the third-leading position in the DBM allograft market. JunYoung Medical does not manufacture its own products, but instead distributes allograft and DBM allograft products for LifeNet Health.
Other notable competitors included, but were not limited to, Shin Poong, HansBiomed, LG Chem, and DongKook. The presence of local companies in South Korea is strong, and only a few international companies have been able to secure notable share in the orthopedic bone graft substitute market.
Click on each title to view more detailed market segmentation.
- Procedure Volumes for Orthopedic Biomaterials Devices – MedPro – The complete procedural analysis for each segment of the South Korean Orthopedic Biomaterials market.
- Orthopedic Bone Graft Substitute Market – MedCore – This market is segmented by Material Type, including Allograft, Demineralized Bone Matrix Allograft, and Synthetic. Each of these material types are segmented by Indication, including Spine, Trauma, Large Joint Reconstruction, Foot Reconstruction, Craniomaxillofacial, and Oncology.
- Hyaluronic Acid Viscosupplementation Market – MedCore – This market is categorized by Treatment Type, including Single-Injection, Three-Injection and Five-Injection.
Detailed Market Segmentation
DON’T SEE THE SEGMENT OR DATA YOU NEED?
Feel free to contact us or send a request by pressing one of the buttons below.
TABLE OF CONTENTS FOR THE SOUTH KOREAN ORTHOPEDIC BIOMATERIALS MARKETTABLE OF CONTENTS ILIST OF FIGURES VIIILIST OF CHARTS XVEXECUTIVE SUMMARY 1SOUTH KOREAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW 1COMPETITIVE ANALYSIS 3MARKET TRENDS 5MARKET DEVELOPMENTS 6PROCEDURE NUMBERS 7MARKETS INCLUDED 8KEY REPORT UPDATES 10VERSION HISTORY 10RESEARCH METHODOLOGY 11Step 1: Project Initiation & Team Selection 11Step 2: Prepare Data Systems and Perform Secondary Research 14Step 3: Preparation for Interviews & Questionnaire Design 16Step 4: Performing Primary Research 17Step 5: Research Analysis: Establishing Baseline Estimates 19Step 6: Market Forecast and Analysis 20Step 7: Identify Strategic Opportunities 22Step 8: Final Review and Market Release 23Step 9: Customer Feedback and Market Monitoring 24
PRODUCT ASSESSMENT2.1 INTRODUCTION 252.2 PRODUCT PORTFOLIOS 252.2.1 Bone Graft Substitutes 262.2.2 Growth Factors 3220.127.116.11 Other Products 352.2.3 Hyaluronic Acid Viscosupplementation (HAV) 372.3 REGULATORY ISSUES AND RECALLS 402.3.1 Bone Graft Substitutes 402.3.1.1 Allografts 402.3.1.1.1 MTF 402.3.1.2 DBM 402.3.1.2.1 AlloSource 402.3.1.2.2 SeaSpine 418.104.22.168.3 RTI Surgical 422.214.171.124 Synthetics 4126.96.36.199.1 Abyrx 4188.8.131.52.2 Zimmer Biomet 422.3.2 Growth Factors 4184.108.40.206.1 Medtronic 422.3.3 Hyaluronic Acid Viscosupplementation 4220.127.116.11 Three-injection 418.104.22.168.1 Ferring Pharmaceuticals 432.4 CLINICAL TRIALS 442.4.1 Bone Graft Substitutes 422.214.171.124 Allografts 4126.96.36.199.1 Providence Medical Technology 4188.8.131.52.2 The University of Texas Health Science 4184.108.40.206.3 University of Winchester 4220.127.116.11 BDM 418.104.22.168.1 K2M 422.214.171.124.2 Zimmer Biomet 4126.96.36.199 Synthetics 4188.8.131.52.1 Baxter 4184.108.40.206.2 Bonesupport 4220.127.116.11.3 DePuy Synthes 418.104.22.168.4 NuVasive 422.214.171.124.5 RTI surgical 4126.96.36.199.6 Sunstar GUIDOR 502.4.1.4 Other materials and comparison 5188.8.131.52.1 Seoul National University Hospital. 5184.108.40.206.2 Sewon Cellontech 5220.127.116.11.3 SurgaColl Technologies Limited 518.104.22.168.4 University of Colorado 522.214.171.124.5 University of Padova 532.4.2 Growth Factors 5126.96.36.199.1 Bioventus 5188.8.131.52.2 Cerapedics 5184.108.40.206.3 CGBio 5220.127.116.11.4 Isto 518.104.22.168.5 Medtronic 522.214.171.124.6 NuVasive 5126.96.36.199.7 Wright 5188.8.131.52.8 Others 582.4.3 Hyaluronic Acid Viscosupplementation 5184.108.40.206.1 Anika Therapeutics 5220.127.116.11.2 Bioventus 602.4.3.1.3 Cairo University 618.104.22.168.4 Ferring Pharmaceuticals 622.214.171.124.5 Federal University of Minas Gerais 6126.96.36.199.6 Fidia Pharma USA Inc. 6188.8.131.52.7 Istituto Ortopedico Rizzoli 6184.108.40.206.8 University Hospital 6220.127.116.11.9 Universidade Nova de Lisboa 64
SOUTH KOREAN ORTHOPEDIC BIOMATERIALS MARKET OVERVIEW3.1 INTRODUCTION 653.1.1 Bone Graft Substitutes 653.1.2 Growth Factors 653.1.3 Hyaluronic Acid (HA) Viscosupplementation 663.2 CURRENCY EXCHANGE RATE 673.3 MARKET OVERVIEW AND TREND ANALYSIS 683.4 DRIVERS AND LIMITERS 753.4.1 Market Drivers 753.4.2 Market Limiters 753.5 COMPETITIVE MARKET SHARE ANALYSIS 773.6 MERGERS AND ACQUISITIONS 823.7 COMPANY PROFILES 843.7.1 Anika Therapeutics 843.7.2 Bioventus 853.7.3 DePuy Synthes 863.7.4 Ferring Pharmaceuticals 873.7.5 Fidia Pharmaceuticals 883.7.6 Genzyme (Sanofi Group) 893.7.7 Harvest Technologies (Terumo BCT) 903.7.8 Integra LifeSciences 913.7.9 Medtronic 923.7.10 Musculoskeletal Transplant Foundation (MTF) 943.7.11 NuVasive 953.7.12 Orthofix 963.7.13 RTI Surgical 973.7.14 Stryker 983.7.15 Vericel Corporation (formerly Aastrom Bioscience) 993.7.16 Zimmer Biomet 1003.8 SWOT ANALYSIS 1023.8.1 Anika Therapeutics 1023.8.2 Bioventus 1043.8.3 DePuy Synthes 1063.8.4 Ferring Pharmaceuticals 1073.8.5 Fidia Pharmaceuticals 1083.8.7 Harvest Technologies (Terumo BCT) 1103.8.8 Integra LifeSciences 1113.8.9 Medtronic 1123.8.10 Musculoskeletal Transplant Foundation (MTF) 1133.8.11 NuVasive 1143.8.12 Orthofix 1153.8.14 Stryker 1173.8.15 Vericel Corporation (formerly Aastrom Bioscience) 1183.8.16 Zimmer Biomet 119
PROCEDURE NUMBERS4.1 INTRODUCTION 1214.2 PROCEDURES 1224.2.1 Orthopedic Biomaterial Procedures by Segment 1224.2.2 Orthopedic Bone Grafting Procedures 1244.2.2.1 Units per Procedure by Indication 1244.2.2.2 Orthopedic Bone Grafting Procedures by Material 1254.2.2.2.1 Autograft Procedures by Indication 1218.104.22.168.2 Allograft Procedures by Indication 1304.2.2.2.3 DBM Procedures by Indication 1322.214.171.124.4 Synthetic Procedures by Indication 13126.96.36.199 Orthopedic Bone Grafting Procedures by Indication 1394.2.3 Hyaluronic Acid Viscosupplementation Procedures 14188.8.131.52 Hyaluronic Acid Viscosupplementation Procedures by Injection Cycle 142
ORTHOPEDIC BONE GRAFT SUBSTITUTE MARKET5.1 INTRODUCTION 1445.2 MARKET OVERVIEW 1455.2.1 Orthopedic Bone Graft Substitute Market by Material 1455.2.2 Orthopedic Bone Graft Substitute Market by Indication 1505.3 MARKET ANALYSIS AND FORECAST 1565.3.1 Total Orthopedic Bone Graft Substitute Market 1565.3.2 Orthopedic Bone Graft Substitute Market by Material 15184.108.40.206 Allograft Bone Graft Substitute Market 15220.127.116.11.1 Allograft Bone Graft Substitute Market by Indication 1618.104.22.168 Demineralized Bone Matrix Allograft Bone Graft Substitute Market 1722.214.171.124.1 Demineralized Bone Matrix Allograft Bone Graft Substitute Market by Indication 17126.96.36.199 Synthetic Bone Graft Substitute Market 19188.8.131.52.1 Synthetic Bone Graft Substitute Market by Indication 1955.3.3 Orthopedic Bone Graft Substitute Market by Indication 2095.3.3.1 Spine Bone Graft Substitute Market 2095.3.3.2 Cervical Spine Bone Graft Substitute Market 2184.108.40.206 Thoracolumbar Spine Bone Graft Substitute Market 2220.127.116.11 Trauma Bone Graft Substitute Market 218.104.22.168 Non-Union Trauma Bone Graft Substitute Market 222.214.171.124 Fresh Fracture Trauma Bone Graft Substitute Market 2126.96.36.199 Large Joint Reconstruction Bone Graft Substitute Market 2188.8.131.52 Hip Reconstruction Bone Graft Substitute Market 22184.108.40.206 Knee Reconstruction Bone Graft Substitute Market 22220.127.116.11 Foot Reconstruction Bone Graft Substitute Market 2305.3.3.11 Craniomaxillofacial Bone Graft Substitute Market 2318.104.22.168 Oncology Bone Graft Substitute Market 2365.4 DRIVERS AND LIMITERS 2395.4.1 Market Drivers 2395.4.2 Market Limiters 2395.5 COMPETITIVE MARKET SHARE ANALYSIS 241
HYALURONIC ACID VISCOSUPPLEMENTATION MARKET6.1 INTRODUCTION 2456.1.1 Benefits of Viscosupplementation 2466.1.2 Synovial Fluid 2466.2 MARKET OVERVIEW 2476.3 MARKET ANALYSIS AND FORECAST 2536.3.1 Total Hyaluronic Acid Viscosupplementation Market 2536.3.2 Single-Injection Hyaluronic Acid Viscosupplementation Market 2566.3.3 Three-Injection Hyaluronic Acid Viscosupplementation Market 2596.3.4 Five-Injection Hyaluronic Acid Viscosupplementation Market 2626.4 DRIVERS AND LIMITERS 2656.4.1 Market Drivers 2656.4.2 Market Limiters 2656.5 COMPETITIVE MARKET SHARE ANALYSIS 267
APPENDIX: ORTHOPEDIC GROWTH FACTOR MARKET7.1 INTRODUCTION 2717.1.1 BMP-2 (Cellumed, CG Bio) 272
iData’s 9-Step Research MethodologyOur reports follow an in-depth 9-step methodology which focuses on the following research systems:
- Original primary research that consists of the most up-to-date market data
- Strong foundation of quantitative and qualitative research
- Focused on the needs and strategic challenges of the industry participants
Step 1: Project Initiation & Team Selection During this preliminary investigation, all staff members involved in the industry discusses the topic in detail.
Step 2: Prepare Data Systems and Perform Secondary Research The first task of the research team is to prepare for the data collection process: Filing systems and relational databases are developed as needed.
Step 3: Preparation for Interviews & Questionnaire Design The core of all iData research reports is primary market research. Interviews with industry insiders represent the single most reliable way to obtain accurate, current data about market conditions, trends, threats and opportunities.
Step 4: Performing Primary Research At this stage, interviews are performed using contacts and information acquired in the secondary research phase.
Step 5: Research Analysis: Establishing Baseline Estimates Following the completion of the primary research phase, the collected information must be synthesized into an accurate view of the market status. The most important question is the current state of the market.
Step 6: Market Forecast and Analysis iData Research uses a proprietary method to combine statistical data and opinions of industry experts to forecast future market values.
Step 7: Identify Strategic Opportunities iData analysts identify in broad terms why some companies are gaining or losing share within a given market segment.
Step 8: Final Review and Market Release An integral part of the iData research methodology is a built-in philosophy of quality control and continuing improvement is integral to the iData philosophy.
Step 9: Customer Feedback and Market Monitoring iData philosophy of continuous improvement requires that reports and consulting projects be monitored after release for customer feedback and market accuracy.